Viral oncoproteins discriminate between p53 and the p53 homolog p73

被引:172
作者
Marin, MC
Jost, CA
Irwin, MS
DeCaprio, JA
Caput, D
Kaelin, WG
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
[3] Howard Hughes Med Inst, Boston, MA 02115 USA
[4] Sanofi Rech, Labege, France
关键词
D O I
10.1128/MCB.18.11.6316
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p73 is a recently identified member of the p53 family. Previously it was shown that p73 can, when overproduced in p53-defective tumor cells, activate p53-responsive promoters and induce apoptosis. In this report we describe the generation of anti-p73 monoclonal antibodies and confirm that two previously described p73 isoforms are produced in mammalian cells. Furthermore, we show that these two isoforms can bind to canonical p53 DNA-binding sites in electrophoretic mobility shift assays. Despite the high degree of similarity between p53 and p73, we found that adenovirus E1B 55K, simian virus 40 T, and human papillomavirus E6 do not physically interact with p73. The observation that viral oncoproteins discriminate between p53 and p73 suggests that the functions of these two proteins may differ under physiological conditions. Furthermore, they suggest that inactivation of p73 may not be required for transformation.
引用
收藏
页码:6316 / 6324
页数:9
相关论文
共 52 条
[1]  
[Anonymous], 1988, Antibodies: A Laboratory Manual
[2]   ENHANCED DEGRADATION OF P53 PROTEIN IN HPV-6 AND BPV-1 E6-IMMORTALIZED HUMAN MAMMARY EPITHELIAL-CELLS [J].
BAND, V ;
DALAL, S ;
DELMOLINO, L ;
ANDROPHY, EJ .
EMBO JOURNAL, 1993, 12 (05) :1847-1852
[3]   SITE-SPECIFIC BINDING OF WILD-TYPE-P53 TO CELLULAR DNA IS INHIBITED BY SV40-T ANTIGEN AND MUTANT P53 [J].
BARGONETTI, J ;
REYNISDOTTIR, I ;
FRIEDMAN, PN ;
PRIVES, C .
GENES & DEVELOPMENT, 1992, 6 (10) :1886-1898
[4]   A PROTEOLYTIC FRAGMENT FROM THE CENTRAL REGION OF P53 HAS MARKED SEQUENCE-SPECIFIC DNA-BINDING ACTIVITY WHEN GENERATED FROM WILD-TYPE BUT NOT FROM ONCOGENIC MUTANT P53-PROTEIN [J].
BARGONETTI, J ;
MANFREDI, JJ ;
CHEN, XB ;
MARSHAK, DR ;
PRIVES, C .
GENES & DEVELOPMENT, 1993, 7 (12B) :2565-2574
[5]  
BRAITHWAITE AW, 1991, ONCOGENE, V6, P781
[6]  
CHENG NC, 1995, ONCOGENE, V10, P291
[7]  
CHIBA I, 1990, ONCOGENE, V5, P1603
[8]   CRYSTAL-STRUCTURE OF A P53 TUMOR-SUPPRESSOR DNA COMPLEX - UNDERSTANDING TUMORIGENIC MUTATIONS [J].
CHO, YJ ;
GORINA, S ;
JEFFREY, PD ;
PAVLETICH, NP .
SCIENCE, 1994, 265 (5170) :346-355
[9]   WILD-TYPE P53 MEDIATES APOPTOSIS BY E1A, WHICH IS INHIBITED BY E1B [J].
DEBBAS, M ;
WHITE, E .
GENES & DEVELOPMENT, 1993, 7 (04) :546-554
[10]   P53 FUNCTIONS AS A CELL-CYCLE CONTROL PROTEIN IN OSTEOSARCOMAS [J].
DILLER, L ;
KASSEL, J ;
NELSON, CE ;
GRYKA, MA ;
LITWAK, G ;
GEBHARDT, M ;
BRESSAC, B ;
OZTURK, M ;
BAKER, SJ ;
VOGELSTEIN, B ;
FRIEND, SH .
MOLECULAR AND CELLULAR BIOLOGY, 1990, 10 (11) :5772-5781